A blinded randomised cross-over study of the effect of melatonin treatment of sleep disturbances on hypothalamic-pituitary-gonadal axis and leptin in pubertal children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN31542578

Enrollment

Registered

2003-09-12

Start date

2001-01-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases: Sleep disorders Nervous System Diseases Sleep disorders

Interventions

1. Melatonin 2. Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Gonadotrophin and sex hormone levels 2. Urinary melatonin	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026